Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis

OBJECTIVES: We assessed the influence of tocilizumab (TCZ), a humanised monoclonal anti-interleukin-6 receptor antibody, on antibody response following influenza vaccination in patients with rheumatoid arthritis (RA). METHODS: A total of 194 RA patients received inactive trivalent influenza vaccinat...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Shunsuke, Ueki, Yukitaka, Hirakata, Naoyuki, Oribe, Motohiro, Hidaka, Toshihiko, Oishi, Kazunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2012
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595981/
https://www.ncbi.nlm.nih.gov/pubmed/22887851
http://dx.doi.org/10.1136/annrheumdis-2012-201950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595981/
https://www.ncbi.nlm.nih.gov/pubmed/22887851
http://dx.doi.org/10.1136/annrheumdis-2012-201950

Ejemplares similares